EME SELF MONITORING BLOOD GLUCOSE SYSTEM, EME PRO SELF MONITORING BLOOD GLUCOSE SYSTEM

Glucose Dehydrogenase, Glucose

EPS BIO TECHNOLOGY CORP.

The following data is part of a premarket notification filed by Eps Bio Technology Corp. with the FDA for Eme Self Monitoring Blood Glucose System, Eme Pro Self Monitoring Blood Glucose System.

Pre-market Notification Details

Device IDK112901
510k NumberK112901
Device Name:EME SELF MONITORING BLOOD GLUCOSE SYSTEM, EME PRO SELF MONITORING BLOOD GLUCOSE SYSTEM
ClassificationGlucose Dehydrogenase, Glucose
Applicant EPS BIO TECHNOLOGY CORP. No.8, R&D Rd. III, Hsinchu Science Park, Hsinchu City,  TW 30077
ContactCynthia Hung
CorrespondentCynthia Hung
EPS BIO TECHNOLOGY CORP. No.8, R&D Rd. III, Hsinchu Science Park, Hsinchu City,  TW 30077
Product CodeLFR  
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2011-10-03
Decision Date2011-12-23

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
30856276008827 K112901 000
00856276008819 K112901 000
B492301500 K112901 000
00850031608702 K112901 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.